Lupin and Gan & Lee enter exclusive licensing deal for novel GLP-1 receptor agonist
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
Marks first international filing for Evofem’s single-dose oral treatment
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
PEEK brings a new quality to dental care for patients
Subscribe To Our Newsletter & Stay Updated